Home » CRASHING THE STENT PARTY
CRASHING THE STENT PARTY
Conor Medsystems is developing a new breed of stent that may have the power
to swipe large swaths of business from rivals such as Johnson & Johnson
and Boston Scientific. But the company's chief executive officer, Dr. Frank
Litvack, has a controversial past, and there are thorny questions about potential
conflicts of interest and litigation that could torpedo its fortunes.
BusinessWeek
Online
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May